View in EDS

Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events-a narrative review.

Saved in:
Bibliographic Details
Title: Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events-a narrative review.
Authors: Iinuma K; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Tomioka M; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Taniguchi T; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Kawase K; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Tobisawa Y; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Nakane K; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Koie T; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.
Source: Translational cancer research [Transl Cancer Res] 2025 Nov 30; Vol. 14 (11), pp. 8142-8153. Date of Electronic Publication: 2025 Nov 24.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41378040
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events-a narrative review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Iinuma+K%22">Iinuma K</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Tomioka+M%22">Tomioka M</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Taniguchi+T%22">Taniguchi T</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Kawase+K%22">Kawase K</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Tobisawa+Y%22">Tobisawa Y</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Nakane+K%22">Nakane K</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Koie+T%22">Koie T</searchLink>; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101585958%22">Translational cancer research</searchLink> [Transl Cancer Res] 2025 Nov 30; Vol. 14 (11), pp. 8142-8153. <i>Date of Electronic Publication: </i>2025 Nov 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pioneer+Bioscience+Publishing+Company%22">Pioneer Bioscience Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101585958 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2219-6803 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222218676X%22">2218676X </searchLink><i>NLM ISO Abbreviation: </i>Transl Cancer Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41378040
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/tcr-2025-1859
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 8142
    Titles:
      – TitleFull: Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events-a narrative review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Iinuma K
      – PersonEntity:
          Name:
            NameFull: Tomioka M
      – PersonEntity:
          Name:
            NameFull: Taniguchi T
      – PersonEntity:
          Name:
            NameFull: Kawase K
      – PersonEntity:
          Name:
            NameFull: Tobisawa Y
      – PersonEntity:
          Name:
            NameFull: Nakane K
      – PersonEntity:
          Name:
            NameFull: Koie T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 11
              Text: 2025 Nov 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2219-6803
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Translational cancer research
              Type: main
ResultId 1